SHIRE Trademark

Trademark Overview

On Wednesday, July 13, 2016, a trademark application was filed for SHIRE with the United States Patent and Trademark Office. The USPTO has given the SHIRE trademark a serial number of 87102856. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Shire Pharmaceutical Holdings Ireland Limited. The SHIRE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

A full line of pharmaceuticals, namely, pharmaceuticals for the treatment of angioedema, cancer, eating disorders, enzyme deficiencies, gastrointestinal disorders, genetic diseases, hematologic disorders, hormonal disorders, immunologic disorders, neurological disorders, ophthalmic disorders and protein deficiencies; drug delivery apparatus, namely, pre-filled medical fluid injectors for the delivery of pharmaceuticals

Providing medical information and health care information; Providing medical information and health care information in connection with patient support programs; Providing medical information and health care information to improve understanding about pharmaceuticals and medical treatments by health care providers, patients, patients' families and the general public; Health care services
shire

General Information

Serial Number87102856
Word MarkSHIRE
Filing DateWednesday, July 13, 2016
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6200622
Registration DateTuesday, November 17, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2017

Trademark Statements

Goods and ServicesA full line of pharmaceuticals, namely, pharmaceuticals for the treatment of angioedema, cancer, eating disorders, enzyme deficiencies, gastrointestinal disorders, genetic diseases, hematologic disorders, hormonal disorders, immunologic disorders, neurological disorders, ophthalmic disorders and protein deficiencies; drug delivery apparatus, namely, pre-filled medical fluid injectors for the delivery of pharmaceuticals
Goods and ServicesProviding medical information and health care information; Providing medical information and health care information in connection with patient support programs; Providing medical information and health care information to improve understanding about pharmaceuticals and medical treatments by health care providers, patients, patients' families and the general public; Health care services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 19, 2016
Primary Code005
First Use Anywhere DateMonday, November 30, 1998
First Use In Commerce DateMonday, November 30, 1998
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 19, 2016
Primary Code044
First Use Anywhere DateMonday, November 30, 1998
First Use In Commerce DateMonday, November 30, 1998

Trademark Owner History

Party NameTAKEDA PHARMACEUTICALS INTERNATIONAL AG
Party Type32 - New Owner After Registration
Legal Entity Type25 - NOT AVAILABLE
AddressGLATTPARK-OPFIKON 8152
CH
Party NameSHIRE PHARMACEUTICALS IRELAND LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type77 - NOT AVAILABLE
AddressDUBLIN D02 Y754
IE
Party NameShire Pharmaceutical Holdings Ireland Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressDublin 2
IE
Party NameShire Pharmaceutical Holdings Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressDublin 2
IE
Party NameShire Pharmaceutical Holdings Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressDublin 24
IE

Trademark Events

Event DateEvent Description
Saturday, July 16, 2016NEW APPLICATION ENTERED
Tuesday, July 19, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 24, 2016ASSIGNED TO EXAMINER
Friday, October 28, 2016PRIORITY ACTION WRITTEN
Friday, October 28, 2016PRIORITY ACTION E-MAILED
Friday, October 28, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, April 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 7, 2018SOU TEAS EXTENSION RECEIVED
Sunday, January 7, 2018SOU EXTENSION 1 FILED
Sunday, January 7, 2018SOU EXTENSION 1 GRANTED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 5, 2018SOU TEAS EXTENSION RECEIVED
Thursday, July 5, 2018SOU EXTENSION 2 FILED
Thursday, July 5, 2018SOU EXTENSION 2 GRANTED
Saturday, July 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2019SOU TEAS EXTENSION RECEIVED
Friday, January 4, 2019SOU EXTENSION 3 FILED
Friday, January 4, 2019SOU EXTENSION 3 GRANTED
Tuesday, January 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 4, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 4, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 4, 2019SOU TEAS EXTENSION RECEIVED
Thursday, July 4, 2019SOU EXTENSION 4 FILED
Thursday, July 4, 2019SOU EXTENSION 4 GRANTED
Saturday, July 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 15, 2020SOU TEAS EXTENSION RECEIVED
Friday, January 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 15, 2020SOU EXTENSION 5 FILED
Friday, January 17, 2020SOU EXTENSION 5 GRANTED
Saturday, January 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, June 25, 2020USE AMENDMENT FILED
Friday, June 26, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 20, 2020SU - NON-FINAL ACTION - WRITTEN
Monday, July 20, 2020NON-FINAL ACTION E-MAILED
Monday, July 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 13, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 14, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, November 25, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 17, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

shire disorders information health care medical pharmaceuticals providing deficiencies patients delivery